So it's rather timely that I stumbled upon another review, this time published in this month's issue of Annals of Family Medicine, in which the authors concluded that use of cinnamon in Type 2 diabetes could potentially lower fasting glucose & improve a typical lipid panel by raising HDL while lowering total & LDL cholesterol along w/triglycerides. However, while use of cinnamon did lower fasting glucose, it did not appear to lower Hemoglobin A1c, a 3 month measure of average sugar control. In all fairness, this review & meta-analysis also included 10 studies (perhaps the same 10?) but this time including just 543 participants.
As the authors noted, the range of doses (from 120mg/d to 6g/d) along with the short duration of individual studies (from 4-18 weeks) made the data too heterogenous to conclude anything more than a need to study the use of cinnamon more rigorously in diabetes. And as I've learned while perusing several websites in preparing to post this blog, we also have to become more specific as to which cinnamon plant we are referring as well as develop a potentially more objective measure than just dose/weight, since the potential benefit may be derived from the 0.5-1% that consists of aromatic oils.
Bottom line, for now, there may be some truth in those miraculous TV ads. However, to be safe, don't buy your cinnamon without knowing its source (unlike Reumofan for which we have no idea of its manufacturer).
Tweet
This site complies with the HONcode standard for trustworthy health information:
verify here.
No comments:
Post a Comment